The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions
Background: Glioblastoma multiforme is a malignant intracranial neoplasm that constitutes a therapeutic challenge because of the associated high morbidity and mortality given the lack of effective approved medication and aggressive nature of the tumor. However, there has been extensive research rece...
Main Authors: | Karam Khaddour, Tanner M. Johanns, George Ansstas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/11/389 |
Similar Items
-
Current Immunotherapies for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2021-03-01) -
Discovery and Application of Neoepitopes in an Oncolytic Rhabdovirus Vaccine Approach to Treat Glioblastoma Multiforme
by: Jilesen, Zachary Keavin
Published: (2019) -
Validating Transgenic Farmington Viruses for the Treatment of Glioblastoma Multiforme
by: Rowe, Katelynn
Published: (2015) -
Immunotherapy in Glioblastoma: A Clinical Perspective
by: Nicolas Desbaillets, et al.
Published: (2021-07-01) -
Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
by: Andrea eSchuessler, et al.
Published: (2014-10-01)